124 related articles for article (PubMed ID: 29630860)
1. Targeting mitochondrial respiration as a therapeutic strategy for cervical cancer.
Tian S; Chen H; Tan W
Biochem Biophys Res Commun; 2018 May; 499(4):1019-1024. PubMed ID: 29630860
[TBL] [Abstract][Full Text] [Related]
2. Targeting mitochondria by anthelmintic drug atovaquone sensitizes renal cell carcinoma to chemotherapy and immunotherapy.
Chen D; Sun X; Zhang X; Cao J
J Biochem Mol Toxicol; 2018 Sep; 32(9):e22195. PubMed ID: 30004155
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of antibiotic drug mefloquine against cervical cancer through impairing mitochondrial function and inhibiting mTOR pathway.
Li H; Jiao S; Li X; Banu H; Hamal S; Wang X
Can J Physiol Pharmacol; 2017 Jan; 95(1):43-50. PubMed ID: 27831748
[TBL] [Abstract][Full Text] [Related]
4. Atovaquone enhances doxorubicin's efficacy via inhibiting mitochondrial respiration and STAT3 in aggressive thyroid cancer.
Lv Z; Yan X; Lu L; Su C; He Y
J Bioenerg Biomembr; 2018 Aug; 50(4):263-270. PubMed ID: 29687367
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of mitochondrial respiration overcomes hepatocellular carcinoma chemoresistance.
Sun Y; Xu H; Chen X; Li X; Luo B
Biochem Biophys Res Commun; 2019 Jan; 508(2):626-632. PubMed ID: 30522865
[TBL] [Abstract][Full Text] [Related]
6. Atovaquone at clinically relevant concentration overcomes chemoresistance in ovarian cancer via inhibiting mitochondrial respiration.
Guo Y; Hu B; Fu B; Zhu H
Pathol Res Pract; 2021 Aug; 224():153529. PubMed ID: 34174549
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of mitochondrial respiration by tigecycline selectively targets thyroid carcinoma and increases chemosensitivity.
Wang Y; Xie F; Chen D; Wang L
Clin Exp Pharmacol Physiol; 2019 Oct; 46(10):890-897. PubMed ID: 31209921
[TBL] [Abstract][Full Text] [Related]
8. Potent inhibition of tumour cell proliferation and immunoregulatory function by mitochondria-targeted atovaquone.
Cheng G; Hardy M; Topchyan P; Zander R; Volberding P; Cui W; Kalyanaraman B
Sci Rep; 2020 Oct; 10(1):17872. PubMed ID: 33087770
[TBL] [Abstract][Full Text] [Related]
9. Anthelminthic drug niclosamide sensitizes the responsiveness of cervical cancer cells to paclitaxel via oxidative stress-mediated mTOR inhibition.
Chen L; Wang L; Shen H; Lin H; Li D
Biochem Biophys Res Commun; 2017 Mar; 484(2):416-421. PubMed ID: 28137584
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic drug levofloxacin inhibits proliferation and induces apoptosis of lung cancer cells through inducing mitochondrial dysfunction and oxidative damage.
Song M; Wu H; Wu S; Ge T; Wang G; Zhou Y; Sheng S; Jiang J
Biomed Pharmacother; 2016 Dec; 84():1137-1143. PubMed ID: 27780143
[TBL] [Abstract][Full Text] [Related]
11. The anti-malarial atovaquone selectively increases chemosensitivity in retinoblastoma via mitochondrial dysfunction-dependent oxidative damage and Akt/AMPK/mTOR inhibition.
Ke F; Yu J; Chen W; Si X; Li X; Yang F; Liao Y; Zuo Z
Biochem Biophys Res Commun; 2018 Oct; 504(2):374-379. PubMed ID: 29902460
[TBL] [Abstract][Full Text] [Related]
12. Repositioning of antibiotic levofloxacin as a mitochondrial biogenesis inhibitor to target breast cancer.
Yu M; Li R; Zhang J
Biochem Biophys Res Commun; 2016 Mar; 471(4):639-45. PubMed ID: 26902121
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting prenylation augments chemotherapy efficacy in renal cell carcinoma through dual inhibition on mitochondrial respiration and glycolysis.
Huang J; Yang X; Peng X; Huang W
Biochem Biophys Res Commun; 2017 Nov; 493(2):921-927. PubMed ID: 28943437
[TBL] [Abstract][Full Text] [Related]
14. Repurposing atovaquone: targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells.
Fiorillo M; Lamb R; Tanowitz HB; Mutti L; Krstic-Demonacos M; Cappello AR; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Oncotarget; 2016 Jun; 7(23):34084-99. PubMed ID: 27136895
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of fisetin combined with sorafenib in human cervical cancer HeLa cells through activation of death receptor-5 mediated caspase-8/caspase-3 and the mitochondria-dependent apoptotic pathway.
Lin MT; Lin CL; Lin TY; Cheng CW; Yang SF; Lin CL; Wu CC; Hsieh YH; Tsai JP
Tumour Biol; 2016 May; 37(5):6987-96. PubMed ID: 26662956
[TBL] [Abstract][Full Text] [Related]
16. Combining PEGylated mito-atovaquone with MCT and Krebs cycle redox inhibitors as a potential strategy to abrogate tumor cell proliferation.
Cheng G; Hardy M; You M; Kalyanaraman B
Sci Rep; 2022 Mar; 12(1):5143. PubMed ID: 35332210
[TBL] [Abstract][Full Text] [Related]
17. Doxycycline inhibits proliferation and induces apoptosis of both human papillomavirus positive and negative cervical cancer cell lines.
Zhao Y; Wang X; Li L; Li C
Can J Physiol Pharmacol; 2016 May; 94(5):526-33. PubMed ID: 26913972
[TBL] [Abstract][Full Text] [Related]
18. NDUFA8 is transcriptionally regulated by EP300/H3K27ac and promotes mitochondrial respiration to support proliferation and inhibit apoptosis in cervical cancer.
Xiang H; Tang H; He Q; Sun J; Yang Y; Kong L; Wang Y
Biochem Biophys Res Commun; 2024 Jan; 693():149374. PubMed ID: 38096616
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic anisomycin induces cell cycle arrest and apoptosis through inhibiting mitochondrial biogenesis in osteosarcoma.
Cao C; Yu H; Wu F; Qi H; He J
J Bioenerg Biomembr; 2017 Dec; 49(6):437-443. PubMed ID: 29164469
[TBL] [Abstract][Full Text] [Related]
20. Preclinical evidence of synergism between atovaquone and chemotherapy by AMPK-dependent mitochondrial dysfunction.
Xie F; Gong J; Tan H; Zhang H; Ma J
Eur J Pharmacol; 2021 Sep; 907():174256. PubMed ID: 34129882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
